Do parental coronary heart disease risk factors (non-modifiable) effect their young ones?  by Kumar, Arun
113
Document heading                                                                                © 2015 by the Asian Pacific Journal of Tropical Biomedicine. All rights reserved.
Do parental coronary heart disease risk factors (non-modifiable) effect their young ones?
Arun Kumar*
Department of Biochemistry, Manipal College of Medical Sciences, Kathmandu University, Pokhara, Nepal
Asian Pac J Trop Biomed 2015; 5(2): 113-123 
Asian Pacific Journal of Tropical Biomedicine
    *Corresponding author: Arun Kumar, Associate Professor, Department of 
Biochemistry, Manipal College of Medical Sciences, Pokhara, Nepal.            
      Tel: +977-9816664537 
      E-mail: arun732003@gmail.com
      Foundation Project: Supported by Confederation of Epidemiological Associations 
registered under Govt of Kerala (Grant No. 30-955/2012 CEA).
1. Introduction
   Coronary heart disease (CHD) is still the leading cause of 
morbidity in the general population[1]. In 2008, five out of the 
top ten causes for mortality worldwide were non-communicable 
diseases (NCDs), which have figured out to be seven out of ten by 
the year 2030 and majority resides in the developing countries. It 
is projected that, by the year 2030, about 76% of the deaths in the 
world would be due to NCDs[2]. India topped the world with 1.5 
million cardiovascular disease (CVD) related diseases deaths in 
2002.
   According to the World Health Organization, CVD is the leading 
cause of death in India now, accounting for 29% of all deaths in 
2005 with almost 100 million people affected. India is set to become 
the heart disease capital of the world[3]. Almost 2 000 people die of 
strokes every day. This alarming increase implies a future increase 
in the financial burden associated with this disease and raises 
the possibility that age-adjusted death rates from coronary artery 
ARTICLE INFO                              ABSTRACT
Objective: To study the differences between the lipid profiles of the subjects whose parents 
are having known non-modifiable risk factors such as obesity, hypertension (HTN), myocardial 
infarction and diabetes, and compare them with the lipid profiles of the subjects whose parents 
are not having those risk factors.
Methods: A total of 402 subjects were recruited to this study. A detailed questionnaire which 
included information on the past medical history, height, weight, blood pressure, physical 
activity, smoke, alcohol, family history of coronary heart disease, HTN, diabetics and obesity. 
Basic demographic data and dietary habits were completed by all participants. Blood samples 
were obtained from all subjects after 14 h. Lipid profiles were analyzed using automated 
analyzer. The results were analyzed using SPSS software packages.
Results: The mean body mass index of the population was well below the cut-off value of 
obesity (>24.5 kg/m2) and high risk of future cardiovascular disorder (CVD) events in this 
age group. The mean levels of total cholesterol (TC), triglycerides (TG) and TC/high density 
lipoprotein (HDL) were less than the risk levels indicative of future CVD events according to 
the ATP III cut-off values. However the mean HDL level in our population was slightly greater 
than the cut-off value while the mean low density lipoprotein level was almost similar to the risk 
level. Differences were observed when the subjects without history of maternal obesity were 
compared with subjects with history of maternal obesity. The greater percentage of subjects 
who are having risk levels of body mass index, TC, low density lipoprotein, TG, and TC/HDL 
indicated that maternal obesity contributed to the greater susceptibility of developing CVD risk 
in their offspring.
Conclusions: Advancing age may result in changes that could be atherogenic in the future. 
Such atherogenic changes have already initiated when the subjects are about 21 years old. 
The incidence of atherogenic changes is far greater when mothers who are having any of the 
risk factors such as obesity, diabetes, HTN and myocardial infarction than that fathers who are 
having similar risk factors.
 Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/apjtb
Article history:
Received 6 Oct 2014
Received in revised form 20 Oct 2014
Accepted 6 Nov 2014
Available online 11 Nov 2014
Keywords:







Arun Kumar/Asian Pac J Trop Biomed 2015; 5(2): 113-123114
disease would be increased[4].
   Even the worldwide obesity levels have drastically increased over 
the couple of decades. As the recent World Health Organization 
estimates over one billion and nearly 300 million adults are 
overweight and obese respectively[5]. In many developed countries, 
the prevalence of obesity has reached epidemic levels and is 
associated with NCDs including diabetes, hypertension (HTN), 
dyslipidemia and CHD[6]. In South Asia, the major health problems 
were infectious diseases and under-nutrition, and very little 
attention was paid to obesity by healthcare workers, policy makers 
or researchers[7]. However, attention is being paid with the rapid 
emergence of the obesity epidemic in South Asian countries now.
   The term risk factor includes modifiable life styles and biochemical 
and physiological characteristics as well as non modifiable personal 
characteristics such as age, gender and family history of early-
onset of CVD found in healthy individuals, which are independently 
related to the subsequent occurrence of CHD. The effects of risk 
factors in adults are additive, i.e. the greater the number of high risk 
factors present, the greater the risk of CVD[8].
   Autopsy studies have shown that early coronary atherosclerosis 
o f t en  beg ins  in  ch i ldhood  and  ado lescence .  Fur the r, 
hypercholesterolaemia in adolescents correlated positively with 
changes in vasculature predictive of later CVD[9]. There is a tendency 
to persistence in ranks (tracking) for total serum and β-lipoprotein 
cholesterol with age[10].
   Hypercholesterolemia in childhood is common in westernized 
countries with high rates of CHD[11]. India is a classical example 
to illustrate drastic changes that occur in societies during the 
industrialization and urbanization or the westernization[12]. Thus 
incidence of chronic diseases due to changes in the dietary patterns 
and physical activity are on the rise among Indians.
   The prevalence of cardiovascular risk factors such as HTN, diabetes 
and obesity are very high among Indian adults in the age group of 
30-65 years old[13]. Furthermore, 12.6% of hypercholesterolemia, 
18.4% of body mass index (BMI) (>24 kg/m2) and 5.8% of diabetic 
were reported among 975 middle aged males of 35-39 years old[14]. 
Therefore the effects of parental CVD risk factors on the future risk 
of CVD in adolescents should be investigated.
   The parental obesity influences childhood obesity through a 
mixture of genetic and environmental mechanisms[15]. Children with 
obese family members are several folds more likely to be obese than 
children whose family members are lean, due to the reason that the 
former has increased preferences for high fat foods but decreased 
physical activity[16]. Furthermore, adolescents with extreme obesity 
(BMI>40 kg/m2) have significantly heavier parents than those with 
Class I or II obesity (BMI<40 kg/m2)[17].
   A substantial amount of weight gain occurs in the transition 
from adolescence to young adulthood with strong tracking from 
adolescence into adulthood[18-21]. It is also suggested that adults who 
become obese in childhood and remained obese into adulthood are 
at higher metabolic risk than those with adult-onset obesity[22]. It has 
been found that maternal obesity was the most significant predictor 
of obesity during childhood[23]. Thus the combination of having an 
obese mother and an earlier onset of obesity translates into higher 
BMI and weight at young adulthood, especially in black children as 
compared with white children[22,23].
   Furthermore, adolescent obesity is associated with increased 
mortality and morbidity related to a variety of chronic diseases later 
in life, and reversal of obesity is associated with decreased metabolic 
risk in adulthood[24,25].
   According to the fetal insulin hypothesis, non-insulin-dependent 
diabetes in parents is associated with lower birth weight among their 
offsprings[26].
   Data on increased risk of non-insulin dependent diabetes for the 
fathers of children with low birth weight confirm that diabetes 
in fathers and the birth weight of their offsprings are strongly 
associated[27]. On the other hand, diabetes in the mother increase the 
birth weight of offspring, which is likely to reflect immediate effects 
of the mother’s metabolic control, possibly masking genetic effects 
operating in the opposite direction[24,28].
   There are very few studies on the effects of history of parental HTN 
on young adults. In such a study of 315 black and white students, 
on the effects of parental HTN on children’s BMI and cardiovascular 
reactivity over time[29], it was concluded that parental HTN 
independently predicted children’s BMI, BMI z score, resting blood 
pressure, and blood pressure reactivity.
   Family history of premature CHD is an independent risk factor 
for cardiovascular events in the offspring due to an increased 
susceptibility to atherosclerosis, and an increased tendency for 
thrombosis or other factors[30].
   It is important to elucidate the mechanism on offspring of parents 
with premature CHD which differs from offspring of parents without 
premature CHD because it would be beneficial to asymptomatic 
adults with a positive family history in determining the need for 
primary preventive therapies[31].
   Increased intima-media thickness, which is a heritable trait, is 
associated with prevalent CHD, peripheral vascular disease and 
incidents of cardiovascular events[30]. It was reported that CHD 
family risk score was correlated with mean increased intima-media 
thickness in whites, but not African-Americans.
   In the Framingham offspring study of 1 662 subjects who 
underwent carotid ultrasonography, it has been found that subclinical 
atherosclerosis, assessed in the carotid arteries, is more prevalent in 
individuals with a family history of CHD. Early-onset parental CHD, 
in particular, identifies offspring with a strong familial predisposition 
to atherosclerosis. This confirms the concept that premature age 
of parental disease identifies a subgroup with a strong familial 
predisposition to vascular disease[30].
   It is evident that the intervention to prevent CVD in adulthood 
may be difficult, particularly in the middle age, of being too late in 
terms of the atherosclerotic process. Therefore, early intervention, 
perhaps starting in childhood, may be more appropriate. It is only in 
the 1980s that adult epidemiological risk factor models have been 
extended to children.
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   Such an approach is based on the following rationale:
   1. The foundations of CHD are laid in infancy and early childhood 
with post mortem studies as evidence for such lesions.
   2. Strong association is between ante-mortem risk factors and post 
mortem observations in young individuals.
   3. Individuals at the upper end of distribution with respect to 
a given risk factor tend to maintain that position relative to their 
parents and family. This phenomenon is referred as tracking.
   Therefore it has been suggested that children and adolescence 
who are at the highest risk for the development of accelerated 
atherosclerosis should be identified by examining cholesterol 
screening on the condition that they have a parent with a history of 
myocardial infarction (MI), obesity, diabetes, HTN, and also angina 
pectoris, peripheral vascular disease, cerebrovascular disease or 
sudden death.
   In addition, cholesterol screening may be considered in children 
and adolescents whose parental history is unobtainable, particularly 
if other cardiovascular risk factors are present.
   Thus our study was designed to study the differences between the 
lipid profiles of the subjects who are having parents with known 
non-modifiable risk factors such as obesity, HTN, MI, and diabetes, 
and compare them with subjects whose parents are not having those 
risk factors.
2. Materials and methods
2.1. Materials
   A total of 402 medical students of the Manipal College of Medical 
Sciences, Kathmandu University were recruited to this study after 
informed consent, of them 167 subjects (41.5%) were females and 
235 subjects (58.5%) were males. All subjects were freshmen and 
represented of Nepal and India.
2.2. Data collection
2.2.1. Questionnaire
   A detailed questionnaire, which included information of the past 
medical history, height, weight, blood pressure, physical activity, 
smoking, alcohol, family history of CHD, HTN, diabetics, obesity, 
basic demographic data and dietary habits was completed by all 
participants.
2.2.2. Blood samples
   Blood samples were obtained from all subjects after 14 h. 
Venepuncture was done in a sitting position and 10 mL samples of 
blood were obtained. All samples were allowed to clot. Serum was 
separated and maintained at 4 °C until analyzed. All analyses were 
commenced within 3 h after collection.
2.3. Laboratory methods
   Total cholesterol (TC) concentration was estimated by enzymatic 
techniques (CHOD-PAP method, Boehringer Mannheim) and high 
density lipoprotein (HDL) concentration by phosphotungstic acid 
magnesium reagents (Boehringer Mannheim) and low density 
lipoprotein cholesterol (LDL-C) by using the Friedewald formula. 
Plasma triglycerides (TG) was estimated by the GPO-PAP method 
(Boehringer Mannheim). All analyses were performed on Erba XL- 
300 autoanalyzer. External and internal quality control procedures 
were used to ensure the levels of precision and accuracy required 
for the TC and lipoprotein cholesterol analyses. The external quality 
control procedures-Randox International Quality Assessment 
Scheme from Randox Laboratories Co. Ltd., United Kingdom were 
used.
2.4. Statistical analysis
   The results were analyzed using SPSS software packages. The aim 
of the statistical analysis was to establish the differences between 
the lipid profile parameters of the young people with respect to 
the presence or absence of history of parental risk factors. Family 
history of CHD was evaluated from the information given in the 
questionnaire.
3. Results   
   The distribution of anthropometric parameters of the subjects was 
obtained. Among the 402 young subjects, only 1.5% of them were 
non-vegetarians.
   The mean body weight, height and BMI of the subjects were 
(52.00±9.75) kg, (161.00±9.30) cm and (20.11±2.91) kg/m2, 
respectively. The mean BMI of the population studied was well 
below the cut-off value of obesity (>24.5 kg/m2) which had higher 
risk of future CVD events in this age group.
   Table 1 shows the results of the biochemical parameters of the 
subjects. The mean levels of TC, TG and TC/HDL were less than the 
risk levels indicative of future CVD events according to the ATP III 
cut-off values[38]. Though the values were within the normal range, 
they were also very closer to the cut-off values. However, the mean 
HDL level in our population was slightly greater than the cut-off 
value while the mean LDL level was almost similar as the risk level. 
Table 1 
The biochemical parameters of the subjects.
Parameter Mean±SD Cut-off levels as per 
NCEP ATP-III
TC (mg/dL) 190.00±35.60   >200
TG (mg/dL) 100.00±40.50   >150
HDL-C (mg/dL) 51.51±4.90 <50
LDL-C (mg/dL) 119.00±31.85   >110
TC/HDL   3.71±0.64                   >4
HDL-C: HDL cholesterol. n=402.
   Table 2 shows the frequency of subjects with risk levels. These 
frequency values indicated that though a very low proportion (8.2%) 
of subjects were with risk values as indicated by anthropometric 
parameter of BMI, all the biochemical parameters indicated much 
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more severe situation as far as the development of future CVD events 
were concerned.
Table 2 
Frequency of subjects with risk levels (n=402).
Parameter Risk level* Abnormal values of subjects
BMI (kg/m2) >24.5 33 (8.20%)
TC (mg/dL) >200 142 (35.30%)
200-239 102 (25.40%)
>239 40 (9.95%)
TG (mg/dL) >150   50 (12.40%)
LDL-C (mg/dL) >110 250 (62.20%)
>200 16 (4.00%)
>130 135 (33.60%)
HDL-C (mg/dL) <50 153 (38.10%)
TC/HDL >4   80 (20.00%)
*: Risk levels as indicated by ATP III.
   The data were then analyzed to see the relationship between 
the presence or absence of obesity in mother and variation in 
anthropometric and biochemical parameters of the subjects (Table 
3).
   Following differences were observed when the subjects without 
history of maternal obesity were compared with subjects with history 
of maternal obesity. Both groups of subjects had similar levels 
of BMI values which indicated no differences of anthropometry. 
However, TC, LDL-C, TC/HDL values of the subjects with a history 
of maternal obesity were significantly higher than the levels of the 
subjects without history of maternal obesity. HDL-C levels were also 
similar in two groups of subjects (Table 3).
Table 3 
The effects of maternal obesity on the lipid pattern of the young 
adolescents.
Parameter Non obese (n=357) Obese (n=45) Significance
Body weight (kg) 51.83±9.66   53.93±10.37 Ns
BMI (kg/m2) 20.05±2.94 20.60±2.68 Ns
TC (mg/dL) 189.00±34.78 203.00±39.84  P<0.009 0
TG (mg/dL)   99.40±40.30 105.51±41.68 Ns
HDL-C (mg/dL) 51.38±4.86 52.56±5.23 Ns
LDL-C (mg/dl) 117.00±31.26 1 370.00±34.29   P<0.008 0
TC/HDL   3.67±0.63   3.97±0.67 P<0.02 7
Ns: Not significant.
   The data in Table 4 also confirmed the fact that greater percentage 
of subjects are having risk levels of BMI, TC, LDL , TG, and TC/ 
HDL indicating that maternal obesity contributes to the greater 
susceptibility of developing CVD risk in their offspring.
Table 4 
Frequency of subjects reaching risk levels with respect to maternal obesity.
Parameter Non Obese (n=357) Obese (n=45)
BMI>24.5 kg/m2    28 (7.8%)     5 (11.1%)
TC>200 mg/dL    120 (33.6%)   22 (48.9%)
LDL>110 mg/dL    215 (60.2%)   35 (77.8%)
TG>150 mg/dL      40 (11.2%)    10 (22.2%)
HDL<50 mg/dL    135 (37.8%)    18 (40.0%)
TC/HDL>4       68 (19.0% )    12 (26.7%)
   When the subjects with a history of paternal obesity were 
compared with those without history of paternal obesity, only BMI 
and the LDL levels were significantly greater in the subjects with 
a history of paternal obesity. This indicated that contribution of 
paternal obesity in creating atherogenic picture in the offspring was 
weaker than that of the history of maternal obesity.
   Frequency of abnormal values in the presence of paternal obesity 
was given in the Table 5. The frequency of subjects with a risk level 
of BMI was greater when paternal obesity (15.8%) was present when 
compared to the presence of maternal obesity (11.1%). Except for 
that, frequencies of subjects with abnormal values of TC, LDL, TG 
were significantly greater in the presence of maternal obesity than 
that of paternal obesity (Tables 3, 5, 6).
Table 5
Frequency of abnormal values in the presence of paternal obesity.
Parameter Non obese (n=373) Obese (n=29) Significance
Body weight (kg)  52.10±9.78 53.16±9.28 Ns
BMI (kg/m2)  20.07±2.88 21.05±3.52 P<0.036
TC (mg/dL)  190.00±35.33 200.00±37.00 Ns
TG (mg/dL)  101.00±41.01 90.32±25.80 Ns
HDL (mg/dL)    51.49±4.93 51.95±4.43 Ns
LDL (mg/dL)  118.00±31.70  132.00±34.00 P<0.028
TC/HDL    3.69±0.63   3.83±0.69 Ns
Ns: Not significant.
Table 6 
Frequency of subjects reaching risk levels with respect to paternal obesity. 
Parameter Non obese (n=383) Obese (n=19)
BMI>24.5 kg/m2 30 (7.8%)   3 (15.8%)
TC>200 mg/dL 135 (35.2%)   7 (36.8%)
LDL>110 mg/dL 237 (61.8%) 13 (68.4%)
TG>150 mg/dL   47 (12.3%)   2 (10.5%)
HDL<50 mg/dL 140 (36.4%)  13 (68.4 %)
TC/HDL> 4   75 (19.6%)   5 (26.3%)
   Our data also indicated that LDL levels were significantly elevated 
in the subjects when both mother (P<0.008 0) and father were obese 
(P<0.028) when compared to the LDL levels of the subjects whose 
parents were not obese. Though there were greater values of TC/ 
HDL when both parents were obese, only the levels in subjects with 
a history of maternal obesity were significant (P<0.027). 
   The distribution of lipid parameters of the subjects were assessed 
with respect to the presence or absence of diabetes in parents and 
data are given in Table 7. The body weight of the subjects with a 
history of maternal diabetes was significantly greater than that of 
the subjects without diabetes (P<0.025). Furthermore, the levels of 
BMI, TC, TG and TC/HDL of the subjects with a history of maternal 
diabetes were all significantly greater than that of the subjects 
without a history of maternal diabetes (Table 7).
Table 7
The distribution of lipid parameters of the subjects with respect to the 
presence or absence of maternal diabetes.
Parameter Non diabetic (n=372) Diabetic (n=30) Significance
Body weight (kg) 51.760±9.760 55.970±8.890 P<0.025
BMI (kg/m2) 20.030±2.950 21.140±2.210 P<0.049
TC (mg/dL) 187.000±36.180 198.530±28.410 P<0.028
TG (mg/dL)   99.000±40.040 117.000±44.530 P<0.036
HDL (mg/dL) 51.490±4.910 51.770±4.950 Ns
LDL (mg/dL) 119.000±32.480 124.000±22.980 Ns
TC/HDL   3.704±0.640   3.905±0.550  P<0.028
Ns: Not significant.
   These frequency data revealed the most unexpected observation. 
Though the mean levels of TC were significantly greater in the 
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subjects with a history of maternal diabetes (Table 7), the number 
of subjects with risk levels were less in the subjects with a history 
of maternal obesity than that of the subjects without a history of 
maternal diabetes. This was because of the TC and LDL levels in 
greater proportion of the subjects (i.e. 7/9 exceeds 290 level for TC 
and 10/16 exceeds 200 level for LDL), which resulted in greater 
mean values for TC and LDL (Table 8). 
Table 8
Frequency of abnormal values with respect to the maternal diabetes. 
Parameter Non diabetic (n=372) Diabetic (n=30)
BMI>24.5 kg/m2 29 (7.8%)   4 (13.3%)
TC>200 mg/dL 133 (35.8%)   9 (30.0%)
LDL>110 mg/dL 234 (62.9%)  16 (53.3%)
TG>150 mg/dL   46 (12.3%)    4 (13.3%)
HDL<50 mg/dL  142 (38.2 %)   10 (33.3%)
TC/HDL> 4   73 (19.6%)     7 (23.3%)
   The body weight of the subjects with a history of paternal diabetes 
was significantly greater than that of the subjects without diabetes 
(P<0.028) (Table 9). Furthermore, the levels of BMI, TC, TG of the 
subjects with a history of paternal diabetes were all significantly 
greater than that of the subjects without a history of diabetes. This 
was also observed in the subjects with a history of maternal diabetes. 
In addition, paternal obesity was associated with significantly 
increased level of LDL.
Table 9 
The distribution of lipid parameters of the subjects with respect to the 
presence or absence of paternal diabetes.
Parameter Non diabetic (n=354) Diabetic (n=48) Significance
Body weight (kg) 51.60±9.34   55.48±11.95 P<0.028
BMI ( kg/m2) 19.95±2.87 21.27±2.97 P<0.003
TC (mg/dL) 189.00±36.00 206.00±32.09 P<0.028
TG (mg/dL) 100.00±40.11 112.00±43.29 P<0.038
HDL (mg/dL) 51.40±5.05 52.29±3.57 Ns
LDL (mg/dL) 108.00±32.22 124.00±28.86 P<0.036 
TC/HDL   3.69±0.64 3.76±0.60 Ns
Ns: Not significant.
   The number of subjects with risk level of BMI was very much 
greater (25.0%) in the group with a history of paternal diabetes 
when compared to the number of subjects without paternal diabetes 
(5.9%). The frequency of subjects with abnormal levels of TC, 
LDL, and TG in the history of paternal diabetes was greater than the 
frequency of subjects without paternal diabetes (Table 10).
Table 10
Frequency of abnormal values with respect to the paternal diabetes.
Parameter Non diabetic (n=354) Diabetic (n=48)
BMI>24.5 kg/m2 21 (5.9%)   12 (25.0%)
TC>200 mg/dL 119 (33.6%)    23 (47.9%)
LDL>110 mg/dL 218 (61.6%)    32 (66.7%)
TG>150 mg/dL   38 (10.7%)    12 (25.0%)
HDL< 50 mg/dL 139 (39.3%)    14 (29.2%)
TC/HDL>4   68 (19.2%)    12 (25.0%)
   The distribution of lipid parameters of the subjects were assessed 
with respect to the presence or absence of a history of maternal HTN 
and data were given in Table 11.
   The body weight, BMI, HDL and TC/HDL of the subjects with a 
history of maternal HTN were no significantly different from that 
of the subjects without a history of HTN (Table 11). However, TC, 
LDL, TG levels of the subjects with a history of maternal HTN was 
significantly greater than that of the subjects without a history of 
HTN. The frequency of subjects with abnormal parameters when the 
maternal HTN was present was given in the Table 12.
Table 11
The distribution of lipid parameters of the first assessment with respect to 
the presence or absence of maternal HTN.
Parameter Non HTN (n=353) HTN (n=49) Significance
Body weight (kg) 51.74±9.55   53.32±10.84 Ns
BMI (kg/m2) 20.02±2.93 20.58±2.54 Ns
TC (mg/dL) 185.90±32.53 202.11±29.43 P<0.001
HDL (mg/dL) 51.29±4.95 51.69±4.48 Ns
LDL(mg/dL) 115.40±27.93 123.40±25.31 P<0.045
TG (mg/dL)      100.72±42.44 114.46±43.56 P<0.045
TC/HDL   3.61±0.55   3.76±0.57 Ns
Ns: Not significant.
Table 12  
Frequency of abnormal values with respect to the maternal HTN.
Parameter Maternal HTN absent   
(n=353)
Maternal HTN present 
(n=49)
BMI: >24.5 kg/m2 21 (6.0%) 12 (24.5%)
TC: >200 mg/dL 126 (35.7%) 16 (32.7%)
LDL: >110 mg/dL 220 (62.3%) 30 (61.2%)
TG: >150 mg/dL   40 (11.3%) 10 (20.4%)
HDL: <50 mg/dL 125 (35.4%) 28 (57.1%)
TC/HDL: >4   53 (15.0%) 27 (55.1%)
   The number of subjects with risk levels of BMI, TG, HDL and TC/
HDL was higher in subjects with a history of maternal HTN. Very
similar to frequencies were observed for TC and LDL as shown in 
Table 13.
Table 13
The distribution of lipid parameters of the subjects with respect to the 
presence or absence of paternal HTN.
Parameter Non HTN (n=351) HTN (n=51) Significance
Body weight (kg) 52.31±9.65   52.09±10.07 Ns
BMI (kg/m2) 20.17±2.92 19.54±2.70 Ns
TC (mg/dL) 186.60±32.78 197.39±29.46 P<0.028
HDL (mg/dL) 51.33±5.00 52.27±4.17 Ns
LDL (mg /dL) 115.61±27.87    142.27±4.17  P<0.001
TG (mg/dL) 101.39±42.59   99.01±42.35 Ns
TC/HDL   3.62±0.56   3.64±0.49 Ns
Ns: Not significant.
   The frequency of abnormal values with and without paternal HTN 
was given in Table 14. It indicated that all parameters were higher in 
subjects whose father were hypertensive.
Table 14
Frequency of abnormal values with respect to the paternal HTN.
Parameter Non Hypertensive (n=351) Hypertensive (n=51)
BMI: >24.5  kg/m2 10 (2.8%) 23 (45.1%)
TC: >200 mg/dL 118 (33.6%) 24 (47.1%)
LDL: >110 mg/dL 123 (35.0%) 27 (52.9%)
TG: >150 mg/dL 26 (7.4%) 24 (47.1%)
HDL: <50 mg/dL 125 (35.6%) 28 (54.9%)
TC/HDL: >4               50 (14.2%) 30 (58.8%)
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   Then the relationships of the incidence of maternal and paternal 
MI on the lipid parameters of the subjects were assessed and results 
were given in Tables 15 and 16.
Table 15
The relationship of the incidence of maternal MI on the lipid parameters of 
the subjects.
Parameter Non MI (n=386) MI (n=16) Significance
Body weight (kg) 52.05±9.81   53.17±4.54 Ns
BMI (kg/m2) 20.11±2.93   20.50±0.84  Ns
TC (mg/dL) 190.00±35.25 223.17±4.99 P<0.01
TG (mg/dL)   99.50±39.75   138.00±70.89  P<0.001
HDL (mg/dL) 55.46±4.92   51.00±2.66  P<0.001
LDL (mg/dL) 108.20±31.66   132.17±44.44  P<0.028
TC/HDL 3.69±0.63     3.94±1.19 Ns
Ns: Not significant.
Table 16 
The relationship of the incidence of paternal MI on the lipid parameters of 
the subjects.
Parameter Non MI (n=382) MI (n=20) Significance
Body weight (kg) 52.07±9.72   52.94±10.92 Ns
BMI (kg/m2) 20.11±2.88 20.27±3.77 Ns
TC (mg/dL) 189.00±34.78 216.71±49.95 P<0.012
TG (mg/dL) 100.03±40.19      102.00±31.3 Ns
HDL (mg/dL) 51.49±4.96 52.00±3.59 Ns
LDL (mg/dL) 117.94±30.78 137.02±30.17 P<0.045
TC/HDL   3.69±0.62   3.97±0.93 Ns
Ns: Not significant.
   No significant difference was observed for mean values of body 
weight, BMI and TC/HDL between the two groups. Significantly 
greater values were observed in TC and TG levels of the subjects 
with a history of maternal MI. However, significantly lower levels 
were observed in HDL of the subjects with a history of maternal MI.
   No significant difference was observed for mean values of body 
weight, BMI and TC/HDL between the two groups. However, TC and 
LDL levels were significantly higher in subjects with paternal MI. 
Further, a significant reduction of HDL (P<0.001) and significant 
elevation of TG was observed in subjects who had a history of 
maternal MI. However, frequency analyses and the effects of parental 
MI on the frequency of subjects with or without a history of parental 
MI were not analyzed due to the fewer number of cases.
4. Discussion
   There are very little data available regarding lipid profiles of young 
adolescents, especially in developing countries. Our study was an 
attempt to determine whether apparently healthy adolescent students
who have family histories of cardiovascular risk factors, could result 
to undesirable anthropometric indices and lipid profiles which may 
increase their predisposition to CVD in their adult life. Our study 
population represented from Nepal, thus any observation reached 
here could easily be extrapolated to predict the relationships in the 
general population.
   There is no acceptable and suggestive cut-off value of obesity 
in adolescent males. It may vary with age and also be affected by 
racial differences. The cut-off value for each group was obtained 
by calculating the BMI using the median height for each age group 
and weight corresponding to the 90th percentile in the NCHS 
standards[32].
   The subjects that were studied in our group were younger (19-
21 years of age) than the subjects (20-25 years of age) reported 
previously[33]. Thus we would expect our subjects to show some 
of the anthropometric and biochemical parameters to approach risk 
levels with the advancement in age. The mean BMI of our subjects 
[(20.11±2.91) kg/m2] was well below the cut-off value (24.5 kg/
m2) indicative of the risk level of future CVD events. The value of 
BMI obtained in the current study is almost similar to the values 
(21.32±2.68 kg/m2) observed in the (sub group) age group of 20-25 
years from Nepal[33]. Furthermore, they also observed 15.70% of the 
subject’s BMI values exceeded 24.5 kg/m2 in the age group of 20-
25 years. When we used the same cut–off level for the subjects in 
our study, 33 subjects (8.0%) had BMI values greater than the cut-off 
value. This indicates the increase in prevalence of obesity between 
age groups of 20-25 years and 19-21 years. It was reported that 
the prevalence of obesity among Nepalese men and women were 
59.1% and 61.8%, respectively, though they used a lower cut-off 
(22 kg/m2) in a study conducted by Sharma[34]. It was also reported 
that the prevalence of overweight was among 9% of the subjects 
in a study conducted in young adolescent females (n=1 303, 18-26 
years of age) from Baroda, India[35]. Moreover, it was reported that 
obesity among 12.6% of the participants under study had Grade I 
and Grade II obesity of 10.1% and 2.5% respectively. In another 
study reported from Chennai, India by Tharkar et al., 13.5% of the 
subjects were reported to be overweight and 7.5% were confirmed 
obese among the 2 376 participants with age group from 8-13 
years[36]. In addition, another study conducted by Mishra et al. 
stated high prevalence of insulin resistance in post-pubertal urban 
Asian Indian children with excess body fat, abdominal adiposity and 
excess truncal subcutaneous fat[37]. In the present study when we 
analyzed the history of their parents, we observed 5/45 (11.1%) of 
the adolescents’ mothers were reported to be obese and 3/19 (15.8%) 
of the adolescents’ fathers were reported to be obese. Thus it is clear 
that with the advancement of age, the mean level of BMI as well as 
the number of subjects with BMI values more than the risk level has 
increased.
   In spite of mean BMI value which was well below the risk level, 
mean values of TC, HDL-C and TC/HDL have reached cut-off values 
of 200 mg/dL, 110 mg/dL and 4 respectively, which indicated all 
biochemical parameters approach to risk levels as given in ATP III 
for adults[38]. The mean HDL-C level has also reached the risk level 
of <50 mg/dL. Therefore, it was clear that even in the presence of 
normal anthropometric as indicated by BMI values, the biochemical 
parameters (lipid profile) have reached risk levels. This proved and 
alarmed the significance of screening of all asymptomatic subjects 
for the presence of abnormal lipid profiles.
   Elevated serum TC contributed to coronary atherosclerosis 
throughout life and also serum cholesterol levels measured in 
young adulthood correlate with CHD rates later in life and over a 
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lifetime[39].
   In Muscatine, Iowa study, for example, reported that 75% of 
children who were 5-18 years old at baseline had TC levels greater 
than the 90th percentile of elevated TC (200 mg/dL) at 20-25 years 
of age[40]. The Bogalusa Heart Study reported that 70% of children 
with elevated TC in childhood were persisted with elevated levels in 
adulthood[41].
   In a study of 611 children who had TC measured at age 12 years 
and subsequently re-measured at age 21-24 years, 49% of those in 
the top quintile of age 12 years distribution remained there, while 
70% of those in the top two quintiles were similarly placed at follow 
up. This phenomenon is called as tracking which is seen in plasma 
TC, but the relationship is variable and less constant than that of 
height or weight. In the Bogalusa Heart Study, higher serum TC 
levels were noted among 67 black boys of 14 years old than in 116 
white boys in the same age group[42].
   Obese children ranging from 2-5 years old have 4 times likelihood 
of becoming obese adults compared with normal weight children[43]. 
About 80% of children who were overweight at 10-15 years old 
became obese adults at 25 years old. About 25% of obese adults 
were overweight during childhood[44]. Obesity in childhood has been 
associated with increased arterial stiffness, carotid intima media 
thickness and increased risk of CHD in adult life[45].
   In a study conducted in India by Madhavan et al., Asian Indian 
adolescents aged 14-18 years consisting of 680 boys and 521 girls 
were reported to have lower levels of serum TC, LDL-C and HDL-C 
and higher levels of TG compared to the same aged population in 
the USA[46]. They also hypothesized that it could be due to dietary 
pattern and physical activity in this age group in India.
   The serum TC concentration in the present study had showed a 
significant increase with increasing age. Though it was thought that 
the serum TC concentration in the age group of 18 years probably 
reflected level that may be found in adults 34, the mean TC value for 
our study being (190.00±35.60) mg/dL (n=402), which indicated 
more than a 15% elevation with the advancing age in young 
adolescents.
   Elevated serum TG are associated with increased risk for CHD and 
with other lipid and non lipid risk factors[47]. A TG level of >150 mg/dL 
is considered as risk level in the ATP III report. TG, however, rises more 
markedly in puberty and this is more so in young adolescents. Some 
species of TG rich lipoproteins, notably, cholesterol-enriched remnant 
lipoproteins, promote atherosclerosis and predispose to CHD[48].
   The mean TG value of our subjects [(100.00±40.50) mg/dL 
(n=402)] was well below the cut-off level as given in the ATP III 
report and it was significantly greater than the value reported in 18-
26 year old students conducted earlier[35]. About (50/402) 12.4% 
subjects in our study had TG levels above the risk level of 150 mg/
dL, while about (16/402) 4.0% subjects had levels greater than 
200 mg/dL, which was very much greater than the number of 
subjects as indicated by risk level of BMI. A study reported at 
Chennai showed TG levels of >118 mg/dL of 2 376 school children 
at the age of 8-13 years[36]. Another study conducted by Misra et 
al. stated the prevalence of TG levels of 117.8 mg/dL among 16% of 
their study subjects from New Delhi[37].
   The role of LDL in atherogenesis is confirmed by a wide variety 
of observational and experimental evidence amassed over several 
decades from animal, pathological, clinical, genetic and different 
types of population studies and also by genetic disorders in which 
serum LDL-C is markedly increased in the absence of other CHD 
risk factors e.g. homozygous and heterozygous form of familial 
hypercholesterolemia[48].
   LDL-C lowering earlier in life slows atherosclerotic plaque 
development and the foundation of the unstable plaque. The 
importance of elevated LDL-C to cause CHD is shown by the fact 
that advanced coronary atherosclerosis and premature CHD occur 
even in the absence of other risk factors[49]. The LDL-C level 
<100 mg/dL throughout life is associated with a very low risk for 
CHD and regarded as optimal. However, atherogenesis occurs even 
when LDL-C levels are near optimal 100-129 mg/dL. At level that 
are borderline high (130-150 mg/dL), atherogenesis proceeds at a 
significant rate.
   In the study of school children (n=611) in Sri Lanka, elevated 
serum LDL-C levels (>110 mg/dL, 2.84 mmol/L) were noted in 134 
subjects (21.9%) and LDL-C were seen in 15.7% of the population 
of 14-18 years children. The percentage of subjects with high LDL-C 
levels was the highest (29.8%) in the age group of 17-18 years[50]. 
Only the mean LDL level has reached the risk level (110 mg/dL) 
for this young population, which indicated increased risk of future 
CVD (while HDL and TC/HDL levels were within the normal level). 
However present study encountered 250 subjects (50%) in the age 
group of 18-21 years who had LDL-C levels >110 mg/dL, while more 
than 130 mg/dL was observed in 135/402 subjects that was 32.3% of 
the subjects, which is considered to be very highly atherogenic.
   A low HDL-C level is strongly and inversely associated with risk for 
CHD[51]. Higher risk for CHD at lower HDL levels is multifactorial 
causation[51]. Although this relationship shows no inflection points, 
any reduction in HDL-C from population means is accompanied by 
increased risk for CHD[51]. Clinical trials provide suggestive evidence 
that raising HDL cholesterol levels will reduce risk for CHD[52]. 
However, it remains uncertain whether raising HDL-C levels alone 
and independent of other changes in lipid and/or nonlipid risk factors 
will reduce risk of CHD.
   The mean HDL-C in our study was (51.51±4.90) mg/dL (n=402), 
which was very closer to the cut-off value as recommended in ATP 
III report. The mean HDL value reported among subjects in the age 
group of 14-18[34] was almost similar to the findings reported by 
Madhavan et al. where they reported the HDL-C levels in Indian 
adolescents ranging from 46.5 mg/dL to 47.7 mg/dL[46]. Study 
of Tharkar et al. also reported HDL-C levels were ≤38 mg/dL in 
school-going children aged 8-13 years[36]. Similarly, Misra et al. 
reported a prevalence of 10% of the study subjects whose HDL-C 
levels were <37 mg/dL[37]. When HDL-C (<35 mg/dL ) levels 
were noted in 27.3% of subjects in the age group of 14-18[34], our 
study reported 38.1% (153/402) subjects who have risk levels of 
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HDL (<50 mg/dL). Study conducted by Dhruv et al. among young 
adolescent girls from Gujrat, India reported that they have lower 
levels of HDL-C [(41.0±2.9) mg/dL] compared to our study, though 
we have used a little higher value as the cut-off value which is 
recommended by ATP III report[35].
   The higher values (>4) of TC/HDL was also thought to indicate 
increased risk of developing CVD. The mean value of TC/HDL in 
our study population was (3.71±0.64) (n=402) which was very close 
to the risk level. Further we also observed 80 subjects (20.0%) had 
greater values than the risk levels. The mean value of HDL-C in the 
study carried out by Dhruv et al. was (41.0±2.9) mg/dL among 1 301 
subjects[35]. Therefore, it was very clear that when compared to the 
anthropometric and biochemical parameters of the younger subjects 
reported earlier in India, both parameters, specially the biochemical 
parameters, varied towards the risk level with the advancement of 
age. So it was very important to see how these parameters vary in the 
subjects with and without parents with non-modifiable risk factors. 
In this study we envisaged to study the effects of the presence of 
these risk factors in the parents, which will be on the changes in lipid 
profiles of young adults.
   A study of adolescent boys in the age group of 14-18 years in Sri 
Lanka was to determine the prevalence of risk factors for CVD in 
later life. It was noted that 33.3% of them had a family history of 
CVD, HTN, diabetes mellitus, or more than one of the above disease 
states[50]. They have not considered the frequency of incidence of 
the presence of risk factors in parents separately. We found that 140 
(34.8%) mothers and 154 (38.3%) fathers had any one of the risk 
factors studied when the presence of risk factors were considered 
separately. This also indicated that the incidence of paternal risk 
factors has increased during the past decade.
   Although some people who actually have a large muscle mass were 
classified as overweight, most persons with BMIs of 25-29.9 kg/m2 
have excess body fat. Overweight and obesity are classified as 
BMI 30 kg/m2 and 25-29.9 kg/m2 respectively, which are not only 
predisposed to CHD, stroke and numerous other conditions, but 
also associate with greater all-cause mortality. People who are 
overweight or obese have a high burden of other CHD risk factors 
including dyslipidemia (high LDL-C, low HDL-C, high VLDL and 
TG), type 2 diabetes and HTN[48]. Obese individuals who do not yet 
have these risk factors are at increased risk for developing them.
   Our data showed that maternal obesity was associated with 
significantly higher levels of TC (P<0.009), LDL-C (P<0.008), TC/
HDL (P<0.02 7) when compared to the same levels in the subjects 
without obese mothers. However, no differences were observed in 
BMI and in HDL-C levels between two groups of subjects. Though 
there were greater values of TC/HDL when both parents were 
considered separately for the presence of obesity, only the levels in 
subjects who had a obese mother were significant (P<0.027). This 
confirmed the previous observation that having an obese mother 
was associated with earlier age at obesity onset across all race/
ethnic groups, particularly non-Hispanic blacks in the study of U.S. 
adolescent followed into adulthood[53]. Early-onset obesity has 
important health consequences because of its association with more 
severe adult obesity and future development of CVD.
   The fact that the significant elevation observed in TC, LDL-C, TC/
HDL levels in subjects of our study when mother was obese and 
only LDL-C has elevated significantly when the father was obese, 
confirmed that obesity with mother was a stronger determinant of 
CVD in the offspring than the obesity in the father as suggested in a 
previous study[54,55].
   When the number of subjects with risk levels was considered, 
higher frequencies were observed in BMI, TC, LDL-C, TG in subjects 
with maternal history of obesity than the subjects without obese 
mothers. The parameters of TC (48.9%) and LDL-C (77.8%) had 
the highest number of subjects with risk levels. Even in the subjects 
without obese mothers, risk levels of LDL were seen in 215 subjects 
(60.2%), which indicated an increase in frequency of elevated LDL.
   When the paternal obesity was considered only the LDL levels 
[(132.00±34.00) mg/dL (n=29) and (118.00±31.70) mg/dL (n=373)] 
were significantly higher in the subjects with obese fathers. Our 
data indicated that maternal obesity was a stronger predictor of CVD 
events in the offspring when compared with the paternal obesity.
   Diabetes is a major, independent risk factor for CHD and other 
forms of CVD and since growing evidence suggests that many people 
with diabetes which carry a risk for CHD are similar to that of people 
with established CHD. It is considered that diabetes should be treated 
as a separate category of higher risk[48].
   In the study reported earlier among the subjects with a family 
history of diabetes (n=110), 16% of the subjects had BMI values 
greater than risk level and 21% had high serum TC level greater than 
the risk level[42].
   Except for TC/HDL, the body weight, BMI, TC, TG and TC/HDL 
levels of the subject with a history of maternal and paternal diabetes 
were significantly greater than that of the subjects without such 
history in our study. However an inverse relationship has been 
established between birth weight and paternal non-insulin dependent 
diabetes mellitus[56]. In addition, paternal diabetes in our study was 
associated with significantly increased level of LDL.
   This frequency data revealed the most unexpected observation. 
Though the mean levels of TC and LDL were significantly greater 
in the subjects with a history of maternal diabetes, the number of 
subjects with risk levels were less in that group. This was because 
of the TC and LDL levels in greater proportion of the subjects with 
a history of diabetes (i.e. 7/9 exceeds 290 level for TC and 10/16 
exceeds 200 level for LDL), which resulted greater mean values for 
TC and LDL. This highlighted the necessity of screening subjects 
individually.
   The number of subjects with risk level of BMI, TC, LDL and 
TG was very much greater in the group with a history of paternal 
diabetes when compared to the number of subjects without paternal 
diabetes.
   Thus our data reveal that history of diabetes in both parents would 
result in a lipid profile that will reaching risk levels when they grew 
up to the adulthood which is more strong with respect to the paternal 
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diabetes.
   Family history of premature CHD has been found as an 
independent risk factor for CVD due to increased susceptibility to 
atherosclerosis and thrombosis[30]. Elucidation of this relationship 
in children and adolescent is very important because of its beneficial 
effects of determining primary preventive therapies[57].
   We encountered only few subjects with parents having MI. It is 
also important to note that all parents of the subjects were <65 years 
and no death of parents was reported among these subjects.
   Body weight and BMI were not significantly different in subjects 
when both of their parents are having history of MI. Though not 
significant, TC/HDL levels were greater in subjects with parents 
having MI. Significantly greater values were observed for TC, TG, 
LDL levels together with a significant reduction of HDL in the 
subjects with a history of maternal MI. In the previous study carried 
out in Sri Lanka, it has been found that of the 48 subjects with a 
family history of CVD, 14.6% had BMI values above the desirable 
range, while 10.4% had high concentration of serum TC (>185 mg/
dL, 4.78 mmol/L)[50].
   The effects of parental MI on the frequency of subjects with or 
without a history of parental MI in our subjects were not analyzed 
due to the fewer number of cases.
   In the previous study carried out in Sri Lanka, it was revealed that 
among the 98 subjects with a family history of HTN, 7.1% had high 
BMI, 12.2 % had high serum TC and 25.5% had high apolipoprotein 
B levels[50].
   We observed an significant elevation in TC and LDL-C in the 
presence of parental HTN in our subjects which was in agreement 
with the finding that parental HTN was an independent risk factor of 
future CVD events[58].
   However, in contrast to the previous study, we did not observed 
any difference in BMI between these two groups. Yet we observed 
higher frequencies for BMI, TG, HDL, TC/HDL in subjects with 
a history of maternal HTN. The frequency of subjects who had 
abnormal values with and without paternal HTN indicated that except 
for TG frequency, all the other parameters were higher in subjects 
with paternal HTN.
   An important finding in our study is that the observation of mean 
BMI among subjects with a family history of CHD, HTN or diabetes 
is significantly higher when compared with those that do not have a 
family history of the above diseases.
   Furthermore, the change towards risk level is much greater when 
mother is having those risk factors than when father is having risk 
factors. From the data available we may conclude that:
   1. Advancing age may result changes that could be atherogenic in 
the future.
   2. Such atherogenic changes have already initiated when they are 
about 21 years of age.
   3. The incidence of atherogenic changes is far greater when 
mothers are having any of the risk factors such as obesity, diabetes, 
HTN and MI than when fathers are having similar risk factors.
   Thus, it is of paramount importance to screen individual 
adolescents when any parent is having any one of the above 
mentioned risk factors.
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